Lp-PLA2-IN-1

Cat. No.: OB0225WX-2086

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Lp-PLA2-IN-1 is a chemical agent designed to suppress the enzymatic activity of lipoprotein-associated phospholipase A2.

Synonym: Lp-PLA2 inhibitor 1; 1420367-28-7; GSK2814338; 8-[[3,5-difluoro-4-[6-(trifluoromethyl)pyridin-3-yl]oxyphenyl]methoxy]-1-methyl-3,4-dihydro-2H-pyrimido[1,2-c]pyrimidin-6-one; Lp-PLA2 inhibitor; 8-((3,5-difluoro-4-((6-(trifluoromethyl)pyridin-3-yl)oxy)benzyl)oxy)-1-methyl-1,2,3,4-tetrahydro-6H-pyrimido[1,6-a]pyrimidin-6-one; 8-((3,5-difluoro-4-((6-(trifluoromethyl)pyridin-3-yl)oxy)benzyl)oxy)-1-methyl-3,4-dihydro-1H-pyrimido[1,6-a]pyrimidin-6(2H)-one

CAS No.: 1420367-28-7

Compound CID: 71236597

Formula: C₂₁H₁₇F₅N₄O₃

Formula Weight: 468.38

Specification

Relative Density: 1.47 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Lp-PLA2-IN-1 is applied in cardiovascular research as a potent inhibitor of lipoprotein-associated phospholipase A2 to investigate the modulation of vascular inflammation and lipid oxidation.